Exchange: NASDAQ·Updated 07:35 PM EDT

MEDP News

News
all
press releases
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Medpace (MEDP) closed at $595.41, marking a +1.34% move from the previous day.
Zacks
More News
Here's How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a market capitalization ofread more...
Benzinga
CON vs. MEDP: Which Stock Is the Better Value Option?
CON vs. MEDP: Which Stock Is the Better Value Option?
Zacks
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
Revvity's raised 2026 outlook, Diagnostics growth and stronger cash flow brighten the setup, but premium valuation and software risks call for selectivity.
Zacks
President & CEO Of Medpace Holdings Makes $403K Sale
August J Troendle, President & CEO at Medpace Holdings (NASDAQ:MEDP), disclosed an insider sell on August 31, according to a recent SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchangeread more...
Benzinga
Why Medpace (MEDP) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
President & CEO At Medpace Holdings Sells $2.90M Of Stock
August J Troendle, President & CEO at Medpace Holdings (NASDAQ:MEDP), disclosed an insider sell on August 27, according to a recent SEC filing. What Happened: Troendle's decision to sell 4,673 shares of Medpaceread more...
Benzinga
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
CON vs. MEDP: Which Stock Is the Better Value Option?
Zacks
Can AI Innovation and CRM Wins Boost Veeva Systems' Q2 Results?
VEEV heads into Q2 with Falcon AI, Vault CRM wins and R&D Cloud growth in focus as revenue and EPS estimates point to double-digit gains.
Zacks

Advertisement|Remove ads.